ArticleBasic and clinical neuroscience2025
Article in Basic and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Reactive gliosis contributes to damage and recovery patterns in hydrocephalus. This research aims to evaluate the impact of Methods: A total of 30 male Wistar rats were injected with 25% kaolin directly into the cisterna magna. Twenty-one days after kaolin injection, hydrocephalic rats were randomly divided into four groups, and the presence of hydrocephalus was confirmed by magnetic resonance imaging (MRI) to determine the lateral ventricle volume. Then, the rats received different doses of OEO for 10 days. Additionally, to assess the expression levels of glial fibrillary acidic protein (GFAP) and ionized calcium-binding adaptor molecule 1 (Iba-1), immunohistochemical and Western blot analyses were performed 10 days after the completion of the treatment course. Results: The size of the lateral ventricle in hydrocephalic rats treated with OEO was less than that in those treated with kaolin alone. Based on GFAP and Iba-1 immunostaining data, hydrocephalic rats showed more reactive astrocytes and activated microglia than OEO-treated animals. The findings of the immunohistochemistry analysis were also validated by Western blot. In terms of GFAP and Iba-1 expression levels, a significant difference was observed between the hydrocephalic control group and rats treated with OEO at a dose of 200 mg/kg/d. Conclusion: Compared to hydrocephalic rats, the OEO-treated groups exhibited stable ventricular dilatation. According to the results of this research, OEO may reduce hydrocephalus-related damage in kaolin-induced rat brains, potentially by lowering the expression of GFAP and Iba-1. Therefore, OEO intervention might be effective as a novel treatment technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.